ロード中...
Met tyrosine kinase inhibitor, PF-2341066, suppresses growth and invasion of nasopharyngeal carcinoma
PURPOSE: We explored the effect of hepatocyte growth factor (HGF)/Met signaling pathway on nasopharyngeal carcinoma (NPC) cells in vitro and in vivo, and investigated the ability of Met tyrosine kinase inhibitor (TKI) to block HGF-induced biological signaling. EXPERIMENTAL DESIGN: Met TKI inhibitor...
保存先:
| 出版年: | Drug Des Devel Ther |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4555972/ https://ncbi.nlm.nih.gov/pubmed/26345996 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S85837 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|